Biome Technologies (BIOM) Competitors GBX 7.07 -0.21 (-2.88%) As of 08/4/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock BIOM vs. DCTA, HDD, ESKN, AGM, VRS, ZED, CRDA, JMAT, ELM, and VCTShould you be buying Biome Technologies stock or one of its competitors? The main competitors of Biome Technologies include Directa Plus (DCTA), Hardide (HDD), Esken (ESKN), Applied Graphene Materials (AGM), Versarien (VRS), Zenova Group (ZED), Croda International (CRDA), Johnson Matthey (JMAT), Elementis (ELM), and Victrex (VCT). These companies are all part of the "specialty chemicals" industry. Biome Technologies vs. Its Competitors Directa Plus Hardide Esken Applied Graphene Materials Versarien Zenova Group Croda International Johnson Matthey Elementis Victrex Directa Plus (LON:DCTA) and Biome Technologies (LON:BIOM) are both small-cap basic materials companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends. Does the media prefer DCTA or BIOM? In the previous week, Directa Plus had 2 more articles in the media than Biome Technologies. MarketBeat recorded 2 mentions for Directa Plus and 0 mentions for Biome Technologies. Directa Plus' average media sentiment score of 1.84 beat Biome Technologies' score of 0.00 indicating that Directa Plus is being referred to more favorably in the media. Company Overall Sentiment Directa Plus Very Positive Biome Technologies Neutral Do institutionals & insiders have more ownership in DCTA or BIOM? 20.5% of Directa Plus shares are owned by institutional investors. Comparatively, 5.5% of Biome Technologies shares are owned by institutional investors. 57.9% of Directa Plus shares are owned by insiders. Comparatively, 79.5% of Biome Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has stronger valuation & earnings, DCTA or BIOM? Directa Plus has higher earnings, but lower revenue than Biome Technologies. Directa Plus is trading at a lower price-to-earnings ratio than Biome Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDirecta Plus£20.29M0.73-£9.74M-£5.62-1.95Biome Technologies£78.36M0.05-£17.71M-£34.34-0.21 Which has more volatility and risk, DCTA or BIOM? Directa Plus has a beta of 0.74, meaning that its share price is 26% less volatile than the S&P 500. Comparatively, Biome Technologies has a beta of 2.26, meaning that its share price is 126% more volatile than the S&P 500. Is DCTA or BIOM more profitable? Biome Technologies has a net margin of -22.60% compared to Directa Plus' net margin of -48.00%. Directa Plus' return on equity of -82.37% beat Biome Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Directa Plus-48.00% -82.37% -22.41% Biome Technologies -22.60%-338.72%-27.95% SummaryDirecta Plus beats Biome Technologies on 8 of the 13 factors compared between the two stocks. Get Biome Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BIOM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIOM vs. The Competition Export to ExcelMetricBiome TechnologiesSpecialty Chemicals IndustryMaterials SectorLON ExchangeMarket Cap£3.65M£8.11B£3.26B£3.07BDividend Yield2.73%3.52%5.20%5.02%P/E Ratio-0.2112.19105.85167.82Price / Sales0.0558.9131,270,591,557,448,600.00340,578.78Price / Cash4.7419.2523.8927.97Price / Book17.834.535.994.55Net Income-£17.71M£220.83M£148.72M£5.90B7 Day Performance-5.10%0.02%2.40%0.54%1 Month Performance-2.88%-0.28%3.09%4.30%1 Year Performance-64.76%-3.15%36.58%58.40% Biome Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIOMBiome TechnologiesN/AGBX 7.07-2.9%N/A-71.1%£3.65M£78.36M-0.2127DCTADirecta PlusN/AGBX 9.90+4.2%N/A-39.2%£13.32M£20.29M-1.76187Insider TradeGap DownHDDHardideN/AGBX 7.51-3.1%N/A+19.7%£5.92M£6.11M-3.1446Gap DownHigh Trading VolumeESKNEskenN/AN/AN/AN/A£714K£114.53M-0.88678Gap DownAGMApplied Graphene MaterialsN/AN/AN/AN/A£643K£127K-20.00160Gap DownVRSVersarienN/AGBX 0.02+6.7%N/A-76.3%£373K£5.32M-0.4070Gap DownHigh Trading VolumeZEDZenova GroupN/AGBX 0.24+2.1%N/A-84.8%£344K£267.34K-0.2011Gap DownCRDACroda International2.3979 of 5 starsGBX 2,627+0.6%GBX 3,133.33+19.3%-33.2%£3.67B£1.63B22.575,852News CoverageInsider TradeJMATJohnson Matthey1.2095 of 5 starsGBX 1,736-1.8%GBX 1,875+8.0%+13.0%£2.90B£11.69B29.50N/AELMElementis1.1134 of 5 starsGBX 171.20-1.6%GBX 170-0.7%+16.5%£1.26B£919.45M-36.321,281Gap UpVCTVictrex1.6263 of 5 starsGBX 690+0.4%GBX 822+19.1%-33.3%£601.90M£285.02M19.601,109Positive NewsDividend IncreaseGap Up Related Companies and Tools Related Companies Directa Plus Competitors Hardide Competitors Esken Competitors Applied Graphene Materials Competitors Versarien Competitors Zenova Group Competitors Croda International Competitors Johnson Matthey Competitors Elementis Competitors Victrex Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:BIOM) was last updated on 8/7/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biome Technologies plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Biome Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
